Table 1.
Baseline patient characteristics prior to transplantation.
| All patients n = 78 | Troponin | P value | |||
|---|---|---|---|---|---|
| Negative (≤0.01) n = 42 | Intermediate (0.01–0.11) n = 28 | Elevated (>0.11) n = 8 | |||
| Age at transplantation | 58.2 | 56.1 | 61.7 | 60.5 | P = 0.11 |
| Sex | P = 0.078 | ||||
| Male | 48 (61.5%) | 30 (71.4%) | 13 (46.4%) | 5 (62.5%) | |
| Female | 30 (38.5%) | 12 (28.6%) | 15 (53.6%) | 3 (37.5%) | |
| History of coronary artery disease | 12 (15.4%) | 4 (9.5%) | 6 (21.4%) | 2 (25.0%) | P = 0.24 |
| History of myocardial infarction | 2 (2.6%) | 1 (2.4%) | 1 (3.6%) | 0 (0.0%) | P = 1.00 |
| Diabetes | 25 (32.1%) | 12 (28.6%) | 11 (39.3%) | 2 (25.0%) | P = 0.60 |
| Hypertension | 28 (35.9%) | 16 (38.1%) | 9 (32.1%) | 3 (37.5%) | P = 0.79 |
| Hyperlipidemia | 13 (16.7%) | 4 (9.5%) | 9 (32.1%) | 0 (0.0%) | P = 0.031 |
| Tobacco use | 29 (37.2%) | 21 (50.0%) | 4 (14.3%) | 4 (50.0%) | P < 0.01 |
| Echocardiogram (n) | 75 (96.2%) | 40 (95.2%) | 27 (96.4%) | 8 (100.0%) | |
| LVEF (%) | 65.1 | 63.9 | 65.8 | 68.9 | P = 0.10 |
| RV mean pressure (mm Hg) | 27.8 | 28.3 | 27.4 | 26 | P = 0.62 |
| LV diastolic size (mm) | 48.5 | 49.6 | 46.7 | 47.9 | P = 0.074 |
| LV systolic size (mm) | 30.2 | 31.3 | 28.9 | 28.1 | P = 0.069 |
| RV size | P = 0.45 | ||||
| Normal | 72 (96.0%) | 38 (95.0%) | 27 (100.0%) | 7 (87.5%) | |
| Mild enlargement | 2 (2.7%) | 1 (2.5%) | 0 (0.0%) | 1 (12.5%) | |
| Moderate enlargement | 1 (1.3%) | 1 (2.5%) | 0 (0.0%) | 0 (0.0%) | |
| Overall function | |||||
| Normal function | 71 (94.7%) | 38 (95.0%) | 25 (92.6%) | 8 (100.0%) | P = 0.47 |
| Wall-motion abnormalities | 4 (5.3%) | 2 (5.0%) | 2 (7.4%) | 0 (0.0%) | |
| Pretransplantation stress test | 71 (91.0%) | 36 (85.7%) | 28 (100.0%) | 7 (87.5%) | P = 0.086 |
LVEF: left ventricular ejection fraction; RV: right ventricle; LV: left ventricle.